![]() |
|
|
Vol. 288, Issue 1, 133-138, January 1999
Department of Pharmacology, College of Medicine, Pusan National
University, Pusan, Korea (C.D.K., H.H.K., K.W.A.); and
Center for
Biofunctional Molecules, Pohang University of Science and Technology,
Pohang, Korea (K.W.H.)
We investigated the mechanism or mechanisms by which rebamipide
protects against the gastric mucosal inflammation associated with
Helicobacter pylori. The production of interleukin
(IL)-8 in association with expression of IL-8 mRNA was greatly
increased in the H. pylori-infected Kato III cells in a
concentration- and time-dependent manner, whereas the secretion of IL-6
and tumor necrosis factor-
was not detectable. The increased
production of IL-8 and expression of IL-8 mRNA were significantly
inhibited by rebamipide (100-1000 µM) in a concentration-dependent
manner. Formyl-methionyl-leucyl-phenylalanine (1 nM), as well as
conditioned medium (CM) that was produced from H.
pylori-infected Kato III cells, caused an increase in surface
expression of CD11b on human neutrophils and an increase in neutrophil
adhesion to the human umbilical vein endothelial cells. Rebamipide also
suppressed the adherence of neutrophils to endothelial cells as well as
the expression of CD11b on neutrophils induced by
formyl-methionyl-leucyl-phenylalanine and CM. Furthermore, CM-induced
neutrophil adhesion to the endothelial cells was significantly
inhibited by IL-8-neutralizing antibody, suggesting that IL-8 is
implicated in the CM-induced neutrophil adhesion to the cultured human
umbilical vein endothelial cells. It is concluded that rebamipide
exerts its preventive effect against H. pylori-evoked
gastric mucosal cell inflammation by inhibition of the neutrophil
adherence to the endothelial cells as well as by suppressing the
surface expression of CD11b on neutrophils and the production of
proinflammatory cytokine such as IL-8 from gastric epithelial cells.
This article has been cited by other articles:
![]() |
W.-H. Sun, S. Tsuji, M. Tsujii, E. S. Gunawan, N. Kawai, A. Kimura, Y. Kakiuchi, M. Yasumaru, H. Iijima, Y. Okuda, et al. Induction of Cyclooxygenase-2 in Rat Gastric Mucosa by Rebamipide, a Mucoprotective Agent J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 447 - 452. [Abstract] [Full Text] |
||||
![]() |
C. D. Kim, Y. K. Kim, S. H. Lee, and K. W. Hong Rebamipide Inhibits Neutrophil Adhesion to Hypoxia/Reoxygenation-Stimulated Endothelial Cells via Nuclear Factor-kappa B-Dependent Pathway J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 864 - 869. [Abstract] [Full Text] |
||||